PT Sampoerna Agro Tbk (IDX:SGRO)

Ligand Pharmaceuticals Balance Sheet

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	702,302	840,602	535,964	535,444	496,313	249,647
Cash & Short-Term Investments	702,302	840,602	535,964	535,444	496,313	249,647
Cash Growth	61.37%	56.84%	0.10%	7.88%	98.81%	48.98%
Accounts Receivable	172,197	177,436	155,768	229,318	74,838	333,216
Other Receivables	129,204	154,604	199,909	87,702	122,964	103,058
Receivables	301,401	332,040	355,677	317,020	197,802	457,197
Inventory	845,483	925,107	608,933	862,167	647,865	620,240
Prepaid Expenses	1,485	4,156	5,615	1,578	2,495	2,692
Other Current Assets	74,859	122,753	109,557	83,939	53,061	47,938
Total Current Assets	1,925,530	2,224,658	1,615,746	1,800,148	1,397,536	1,377,714
Property, Plant & Equipment	7,670,598	7,769,099	7,786,068	7,687,065	7,467,866	7,397,292
Goodwill	7,545	7,545	7,702	7,702	7,702	7,702
Other Intangible Assets	86,647	78,212	80,025	81,012	81,350	82,546
Long-Term Deferred Tax Assets	187,517	182,490	260,209	275,353	264,687	369,597
Other Long-Term Assets	427,650	440,347	317,783	391,958	532,224	509,829
Total Assets	10,305,487	10,702,351	10,067,533	10,243,238	9,751,365	9,744,680
Accounts Payable	482,862	661,520	423,445	417,723	516,886	480,402
Accrued Expenses	163,134	150,966	139,126	108,596	83,108	94,358
Short-Term Debt	300,000	-	-	-	28,538	532,049
Current Portion of Long-Term Debt	429,752	574,479	501,641	477,172	279,527	427,716
Current Portion of Leases	4,509	4,762	13,110	11,343	26,065	25,942
Current Income Taxes Payable	146,391	47,263	56,253	183,721	181,413	93,599
Current Unearned Revenue	156,652	137,564	107,586	125,041	111,822	173,460
Other Current Liabilities	94,665	183,834	68,612	37,213	52,382	59,534
Total Current Liabilities	1,777,965	1,760,388	1,309,773	1,360,809	1,279,741	1,887,060
Long-Term Debt	2,182,382	2,453,568	2,680,902	3,116,397	3,317,894	3,415,105
Long-Term Leases	34,050	35,522	219	13,330	23,686	37,385
Long-Term Deferred Tax Liabilities	16,855	16,959	17,165	17,371	16,875	15,781
Other Long-Term Liabilities	13,611	16,033	352,981	323,438	322,334	324,479
Total Liabilities	4,199,979	4,492,331	4,555,126	5,013,127	5,154,666	5,948,624
Common Stock	363,724	363,724	363,724	363,724	378,000	378,000
Additional Paid-In Capital	583,775	583,775	583,775	583,775	681,231	681,231
Retained Earnings	4,554,388	4,613,143	4,079,088	3,949,531	3,298,307	2,485,425
Treasury Stock	-179	-	-	-	-111,732	-111,732
Comprehensive Income & Other	191,683	203,770	203,856	203,865	206,963	189,355
Total Common Equity	5,693,391	5,764,412	5,230,443	5,100,895	4,452,769	3,622,279
Minority Interest	412,117	445,608	281,964	129,216	143,930	173,777
Shareholders' Equity	6,105,508	6,210,020	5,512,407	5,230,111	4,596,699	3,796,056
Total Liabilities & Equity	10,305,487	10,702,351	10,067,533	10,243,238	9,751,365	9,744,680
Total Debt	2,950,693	3,068,331	3,195,872	3,618,242	3,675,710	4,438,197
Net Cash (Debt)	-2,248,391	-2,227,729	-2,659,908	-3,082,798	-3,179,397	-4,188,550
Net Cash Per Share	-1236.34	-1224.95	-1462.60	-1695.13	-1748.25	-2303.14
Filing Date Shares Outstanding	1,819	1,819	1,819	1,819	1,819	1,819
Total Common Shares Outstanding	1,819	1,819	1,819	1,819	1,819	1,819
Working Capital	147,565	464,270	305,973	439,339	117,795	-509,346
Book Value Per Share	3130.74	3169.66	2876.05	2804.81	2448.43	1991.77
Tangible Book Value	5,599,199	5,678,655	5,142,716	5,012,181	4,363,717	3,532,031
Tangible Book Value Per Share	3078.95	3122.50	2827.81	2756.03	2399.46	1942.15
Land	697,353	694,157	681,096	661,408	656,423	647,438
Buildings	1,361,886	1,342,028	1,268,989	1,221,985	1,192,292	1,133,158
Machinery	2,367,557	2,334,833	2,211,689	2,047,665	1,900,763	1,835,068
Construction In Progress	70,687	61,680	62,812	29,128	17,747	62,201

Updated Oct 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.